Clinical Trials Directory

Trials / Unknown

UnknownNCT05423002

Effect of Different Color Lights on the Internal Clock and Alertness in Humans

Mechanisms of Cone Photoreceptors Contribution on Human Neuroendocrine Physiology and Pupillary Light Responses

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
68 (estimated)
Sponsor
University of Basel · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The main aim of this study is to investigate the effects of cone-modulated light emitted from a visual display on human circadian physiology and cognitive performance in the evening.

Detailed description

The investigators will generate single/multiple cone-isolating contrasts with equivalent stimuli for other cones and melanopsin photoreceptors. The investigators will assess melatonin suppression under three different light scenarios generated using the method of silent substitution by tuning the spectral composition of the light primaries (e.g. LEDs) such that a single target photoreceptor class is maximally stimulated compared to an equal stimulation of the remaining photoreceptors. Additionally, The investigators will examine pupil response, subjective sleepiness, psychomotor vigilance, visual comfort, and skin temperature under three different light scenarios. This allows for new insights into the lights' cone-contribution mechanism to neuroendocrine physiology in the human retina.

Conditions

Interventions

TypeNameDescription
OTHERFlickering light stimuliThe intervention will be exposed to flickering lights (≤200 lux). More specifically, the participants will be asked to be exposed to a specified flickering light (1Hz, 30 seconds On, and 30 seconds OFF) for 2 hours starting at their habitual bedtime (HBT).
OTHERConstant light stimuliThe intervention will be exposed to constant background lights (≤200 lux). The participants will be asked to be exposed to a specified constant light for 2 hours starting at their habitual bedtime (HBT).
OTHERDim lightThis light condition is the baseline (≤10 lux).

Timeline

Start date
2022-06-20
Primary completion
2023-03-15
Completion
2023-09-15
First posted
2022-06-21
Last updated
2022-06-21

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05423002. Inclusion in this directory is not an endorsement.